Skip to main content
ModernaExecutive hire

Moderna Names Juan Andres Chief Operating Officer as Jerh Collins Retires

What happened

Moderna has appointed Juan Andres as its new Chief Operating Officer, a newly created role, effective October 5, 2026.

Source

Article excerpt

Highlighted: the sentence this signal was extracted from

Moderna has named Juan Andres Chief Operating Officer, bringing the longtime manufacturing executive back to the company in a newly created role as the biotechnology company prepares for potential expansion in oncology and scales a broader portfolio of commercial vaccines. Andres will return to Moderna effective Oct. 5, 2026, reporting to CEO Stéphane Bancel and joining the company's Executive Committee. He will work across Moderna on operational priorities and execution while directly leading its manufacturing organization. The company also announced that Jerh Collins, Ph.D., Chief Technical Operations and Quality Officer, will retire following four years at Moderna. Creating the COO position comes as Moderna's operating requirements become more diverse. The company is preparing for the potential launch and manufacturing scale-up of intismeran autogene following positive Phase 3 results, while continuing to develop a broader oncology portfolio. Its infectious disease business has also expanded to five approved vaccines following the recent U.S. Food and Drug Administration approval of Moderna's seasonal influenza vaccine and European Commission marketing authorization of its seasonal flu and COVID combination vaccine. Those developments increase the importance of coordinating manufacturing, portfolio priorities and execution across businesses with different production and...

Keep reading with a free account

The rest of this article, and every signal for Moderna, is in your free account.

Extracted by Autobound

From the Signal API record
Event
Executive hire

What this signalsA new leader often reviews the tools the team uses.

Person
Juan AndresChief Operating Officer
Takes effect
Oct 5, 2026

More executive hire signals at other companies

The full record

From the Signal API record

People

  • Juan AndresChief Operating Officer · Named in the story

Topics and mentions

Job title tags

  • directors
  • management
  • operations

Extraction

Confidence
100%
Detected
Sep 30, 2026
signal_type
news
signal_subtype
hires

Use this data

Get every executive hire signal for Moderna and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Moderna this week?”

  2. Send it to your own tools

    The Signal API returns executive hire signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full news record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/0de59a46-b2df-5978-e2ff-12994bdbe1a1 returns this record as JSON. POST /v1/companies/enrich returns every signal for modernatx.com.

{
  "signal_id": "0de59a46-b2df-5978-e2ff-12994bdbe1a1",
  "signal_type": "news",
  "signal_subtype": "hires",
  "detected_at": "2026-09-30T12:42:59+00:00",
  "company": {
    "name": "Moderna",
    "domain": "modernatx.com"
  },
  "data": {
    "url": "https://www.citybiz.co/article/911435/moderna-names-juan-andres-chief-operating-officer-as-jerh-collins-retires/",
    "title": "Moderna Names Juan Andres Chief Operating Officer as Jerh Collins Retires - citybiz",
    "contact": "Juan Andres",
    "excerpt": "Moderna has named Juan Andres Chief Operating Officer, bringing the longtime manufacturing executive back to the company in a newly created role as the biotechnology company prepares for potential expansion in oncology and scales a broader portfolio of commercial vaccines. Andres will return to Moderna effective Oct. 5, 2026, reporting to CEO Stéphane Bancel and joining the company’s Executive Committee. He will work across Moderna on operational priorities and execution while directly leading its manufacturing organization. The company also announced that Jerh Collins, Ph.D. , Chief Technical Operations and Quality Officer, will retire following four years at Moderna. Creating the COO position comes as Moderna’s operating requirements become more diverse. The company is preparing for the potential launch and manufacturing scale-up of intismeran autogene following positive Phase 3 results, while continuing to develop a broader oncology portfolio. Its infectious disease business has also expanded to five approved vaccines following the recent U.S. Food and Drug Administration approval of Moderna’s seasonal influenza vaccine and European Commission marketing authorization of its seasonal flu and COVID combination vaccine. Those developments increase the importance of coordinating manufacturing, portfolio priorities and execution across businesses with different production and...",
    "summary": "Moderna has appointed Juan Andres as its new Chief Operating Officer, a newly created role, effective October 5, 2026.",
    "planning": true,
    "image_url": "https://www.citybiz.co/wp-content/uploads/2026/09/Juan-Andres.jpg",
    "job_title": "Chief Operating Officer",
    "confidence": 1,
    "published_at": "2026-09-30T12:42:59Z",
    "effective_date": "2026-10-05",
    "job_title_tags": [
      "directors",
      "management",
      "operations"
    ],
    "article_sentence": "Moderna has named Juan Andres Chief Operating Officer, bringing the longtime manufacturing executive back to the company in a newly created role as the biotechnology company prepares for potential expansion in oncology and scales a broader portfolio of commercial vaccines."
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.